lorazepam has been researched along with Catatonia in 193 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
Excerpt | Relevance | Reference |
---|---|---|
"Methamphetamine use was associated with catatonia in a small number of cases in the literature." | 9.41 | Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020. ( Barnett, BS; Becker, R; Carroll, BT; Honaker, L; McIntire, S; Saba, S; Slavnic, B; Vellanki, KD; Weleff, J, 2023) |
"The lorazepam-diazepam protocol can rapidly relieve retarded catatonia in schizophrenia." | 9.17 | Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. ( Huang, TL; Lin, CC, 2013) |
"In view of reports in the literature that catatonia responds well to benzodiazepines, and the possible association between catatonia and seizure disorders, an open prospective study was conducted to explore the possibility that catatonia may be successfully treated with carbamazepine." | 9.09 | Catatonia: an open prospective series with carbamazepine. ( Jordaan, GP; Kritzinger, PR, 2001) |
"Electroconvulsive therapy (ECT) and lorazepam are effective treatments for catatonia." | 9.08 | Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. ( Bush, G; Divadeenam, KM; Francis, A; Petrides, G, 1997) |
"Tacrolimus, a potent posttransplant immunosuppressant, has been associated with major neuropsychiatric complications, including catatonia and psychosis." | 9.01 | Catatonia Due to Tacrolimus Toxicity 16 Years After Renal Transplantation: Case Report and Literature Review. ( Fromson, JA; McMahon, J; Sikavi, D, 2019) |
" He was diagnosed with catatonia and was treated successfully with lorazepam." | 8.84 | [Autism and catatonia: successful treatment using lorazepam. A case study]. ( de Winter, CF; Dhossche, DM; Stolker, JJ; van Dijk, F; Verhoeven, WM, 2007) |
" The patient was diagnosed with catatonia due to benzodiazepine withdrawal and had gradual return to baseline with administration of lorazepam 1 mg intravenous three times per day." | 7.88 | Catatonia due to alprazolam withdrawal. ( Abdelmalak, F; Bornmann, C; Iyengar, S; LaRocca, T, 2018) |
"Lorazepam and electroconvulsive therapy (ECT) are effective treatments for catatonia." | 7.85 | The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients. ( Aksoy, I; Altindag, A; Demir, B; Unal, A, 2017) |
"The resurgence of catatonia following tapering of lorazepam is a common clinical phenomenon." | 7.85 | Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications. ( Ali, SF; Gowda, GS; Jaisoorya, TS; Math, SB, 2017) |
"The lorazepam-diazepam protocol had been proved to rapidly and effectively relieve catatonia in patients with schizophrenia or mood disorder." | 7.85 | The Lorazepam and Diazepam Protocol for Catatonia Due to General Medical Condition and Substance in Liaison Psychiatry. ( Huang, TL; Hung, YY; Lin, CC; Tsai, MC, 2017) |
"The patient was successfully treated for catatonia with lorazepam and electroconvulsive therapy after careful diagnostic workup." | 7.80 | Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report. ( Abbott, CC; Brodsky, A; Deligtisch, A; Evans, D; Khafaja, M; Quinn, DK; Rees, C, 2014) |
"This study aimed to explore the evidence of effectiveness of lorazepam as a first line treatment for catatonia in a tertiary psychiatry centre in India given the lack of facilities for ECT in primary care centers of developing countries." | 7.76 | Response rate of lorazepam in catatonia: a developing country's perspective. ( Math, SB; Narayanaswamy, J; Srinivasaraju, R; Tibrewal, P; Zutshi, A, 2010) |
" Hyperactivity, impulsivity, and inattention improved with lorazepam, suggesting that the attention-deficit/hyperactivity disorder symptoms could be manifestations of catatonia." | 7.73 | PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. ( Ahmed, AA; Balamuth, N; Dell, ML; Elia, J; Friedman, DF; Pati, S; Zimmerman, RA, 2005) |
"The authors describe four cases of catatonia in which topiramate treatment was used." | 7.73 | Topiramate effect in catatonia: a case series. ( McDaniel, WW; Sahota, AK; Spiegel, DR, 2006) |
" The speech catatonic symptoms, previously refractory to various antipsychotics, responded promptly to lorazepam, a benzodiazepine with documented efficacy in the treatment of acute catatonia but not chronic catatonia." | 7.72 | Chronic 'speech catatonia' with constant logorrhea, verbigeration and echolalia successfully treated with lorazepam: a case report. ( Lee, JW, 2004) |
"Acute catatonia of the retarded type responds rapidly to treatment with lorazepam." | 7.69 | Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. ( Gaind, GS; Mazurek, MF; Rosebush, PI, 1994) |
"Case material and retrospective studies support the use of both lorazepam and ECT in treating catatonia, but few prospective investigations exist and none employ quantitative monitoring of response." | 7.69 | Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. ( Bush, G; Dowling, F; Fink, M; Francis, A; Petrides, G, 1996) |
" Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 7.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
"Symptoms of NS and catatonia seem to overlap." | 6.80 | Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study. ( Akena, D; Dhossche, DM; Idro, R; Kakooza-Mwesige, A; Nalugya, J; Opar, BT, 2015) |
"Catatonia is a psychomotor syndrome characterized by concomitant emotional, behavioural and motor symptoms." | 6.75 | Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia. ( Grimm, S; Northoff, G; Richter, A, 2010) |
"The authors report five new cases of catatonia; three patients responded favorably and two failed to respond to lorazepam." | 6.37 | Lorazepam treatment of psychogenic catatonia: an update. ( Kilzieh, N; Salam, SA, 1988) |
"Baclofen was approved for medical use in the United States in 1977 by Food and Drug Administration." | 5.72 | Baclofen and catatonia: a case report. ( Caprara, ALF; Gadamidi, VK; Konduru, SN; Rissardo, JP, 2022) |
" It offers future studies direction for standardizing lorazepam dosing schedules for catatonia management and exploring neurobiological underpinnings for individual catatonic signs that may be potentially different, given these findings." | 5.62 | Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting. ( Aandi Subramaniyam, B; Muliyala, KP; Reddi, VSK; Suchandra, HH, 2021) |
"Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient." | 5.46 | Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. ( Duncan-Azadi, CR; Gormley, A; Johnson, PN, 2017) |
"This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years." | 5.43 | Malignant catatonia responsive to low doses of lorazepam: case report. ( Ando, Sde M; Góis, AF; Matias, DF; Riera, R, 2016) |
"Methamphetamine use was associated with catatonia in a small number of cases in the literature." | 5.41 | Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020. ( Barnett, BS; Becker, R; Carroll, BT; Honaker, L; McIntire, S; Saba, S; Slavnic, B; Vellanki, KD; Weleff, J, 2023) |
"Catatonia is a rare manifestation of benzodiazepine withdrawal in elderly patients who have used it for a long time." | 5.39 | Lorazepam withdrawal catatonia: a case report. ( Khandelwal, SK; Sivakumar, T; Sood, M; Yadav, A, 2013) |
"A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination." | 5.37 | Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. ( Maeda, K; Ogawa, N, 2011) |
"The DSM-IV recognizes catatonia as a subtype of schizophrenia characterized by at least two of the following: motor immobility, excessive motor activity not influenced by external stimuli, and peculiarities of voluntary movement." | 5.37 | Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report. ( Fajardo, K; Grenier, E; John, V; Ko, E; Ryan, M, 2011) |
"Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 5.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
"Catatonia is a psychomotor syndrome with an inability to execute and terminate movements completely, leading consecutively to akinesia and posturing, which both respond almost immediately to benzodiazepines, i." | 5.31 | Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia. ( Bogerts, B; Danos, P; Krug, M; Leschinger, A; Northoff, G; Pfennig, A; Schwarz, A, 2000) |
"The lorazepam-diazepam protocol can rapidly relieve retarded catatonia in schizophrenia." | 5.17 | Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. ( Huang, TL; Lin, CC, 2013) |
"An increasing number of case reports indicate a superior therapeutic response of catatonialike symptoms, such as severe psychomotor disturbance and mutism, associated with psychiatric disorder to the benzodiazepine lorazepam (LO)." | 5.09 | A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism. ( Deuschle, M; Drancoli, J; Heuser, I; Schmider, J; Standhart, H, 1999) |
"In view of reports in the literature that catatonia responds well to benzodiazepines, and the possible association between catatonia and seizure disorders, an open prospective study was conducted to explore the possibility that catatonia may be successfully treated with carbamazepine." | 5.09 | Catatonia: an open prospective series with carbamazepine. ( Jordaan, GP; Kritzinger, PR, 2001) |
"Electroconvulsive therapy (ECT) and lorazepam are effective treatments for catatonia." | 5.08 | Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. ( Bush, G; Divadeenam, KM; Francis, A; Petrides, G, 1997) |
"Tacrolimus, a potent posttransplant immunosuppressant, has been associated with major neuropsychiatric complications, including catatonia and psychosis." | 5.01 | Catatonia Due to Tacrolimus Toxicity 16 Years After Renal Transplantation: Case Report and Literature Review. ( Fromson, JA; McMahon, J; Sikavi, D, 2019) |
"Catatonia in the medically ill appears to have numerous etiologies, although etiology does not seem to modify the general treatment approach of prompt administration of lorazepam." | 4.98 | Catatonia in the medically ill: Etiology, diagnosis, and treatment. The Academy of Consultation-Liaison Psychiatry Evidence-Based Medicine Subcommittee Monograph. ( Carroll, BT; Denysenko, L; Francis, A; Freudenreich, O; Penders, TM; Philbrick, KL; Rex, N; Shaffer, S; Sica, N; Walker, A; Zimbrean, P, 2018) |
" This report shows that lorazepam should be taken into consideration (before moving to ECT), in cases of unresolved catatonia, even if the seizures are reduced with anticonvulsants." | 4.98 | Persistent catatonia following epileptic seizures: a case report and systematic literature search. ( Luykx, JJ; Verbraeken, R, 2018) |
" He was diagnosed with catatonia and was treated successfully with lorazepam." | 4.84 | [Autism and catatonia: successful treatment using lorazepam. A case study]. ( de Winter, CF; Dhossche, DM; Stolker, JJ; van Dijk, F; Verhoeven, WM, 2007) |
"Neuroleptic-induced catatonia is reported in an adolescent patient who responded successfully to lorazepam." | 4.78 | Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. ( Woodbury, MA; Woodbury, MM, 1992) |
" After ruling out organic causes of his symptoms, cannabis-induced catatonia was suspected, and the patient responded immediately and completely to lorazepam administration." | 4.31 | Cannabis-Induced Catatonia in a 15-Year-Old Male: A Case Report. ( Gauthier, T; Keopple, D; Prakash, PB; Vardis, R, 2023) |
" He had a history of neonatal seizures, had been stabilized with vigabatrin, and was seizure free without treatment for several months." | 3.88 | Catatonia Associated With a ( Amad, A; Corfiotti, C; Ferrafiat, V; Jardri, R; Leroy, A; Medjkane, F; Nguyen The Tich, S, 2018) |
" The patient was diagnosed with catatonia due to benzodiazepine withdrawal and had gradual return to baseline with administration of lorazepam 1 mg intravenous three times per day." | 3.88 | Catatonia due to alprazolam withdrawal. ( Abdelmalak, F; Bornmann, C; Iyengar, S; LaRocca, T, 2018) |
"Lorazepam and electroconvulsive therapy (ECT) are effective treatments for catatonia." | 3.85 | The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients. ( Aksoy, I; Altindag, A; Demir, B; Unal, A, 2017) |
"The resurgence of catatonia following tapering of lorazepam is a common clinical phenomenon." | 3.85 | Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications. ( Ali, SF; Gowda, GS; Jaisoorya, TS; Math, SB, 2017) |
" He improved rapidly on levetiracetam and lorazepam, was discharged and received a diagnosis of dementia by his community mental health team shortly afterwards, based on chronic short-term memory loss, functional decline and MRI changes." | 3.85 | Intermittent catatonia and complex automatisms caused by frontal lobe epilepsy in dementia. ( George, R; Langford, A, 2017) |
"Patients with catatonia who had more than one episode of catatonia and were treated with the lorazepam-diazepam protocol were identified." | 3.83 | Relapses and recurrences of catatonia: 30-case analysis and literature review. ( Huang, TL; Hung, YY; Lin, CC; Tsai, MC, 2016) |
"The patient was successfully treated for catatonia with lorazepam and electroconvulsive therapy after careful diagnostic workup." | 3.80 | Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report. ( Abbott, CC; Brodsky, A; Deligtisch, A; Evans, D; Khafaja, M; Quinn, DK; Rees, C, 2014) |
" Here, we report a case of the use of the benzodiazepine antagonist flumazenil before ECT to facilitate the simultaneous use of lorazepam and ECT for the treatment of co-occurring catatonia and obsessive-compulsive disorder." | 3.78 | Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration. ( Furst, BA; Kwon, GE; Makhinson, M; Shuff, MK, 2012) |
"Sequential therapeutic trials for catatonoid frontal signs in clinically-evident frontotemporal dementia (n = 2) revealed differential benefits for lorazepam, amantadine, memantine, pramipexole, aripiprazole, quetiapine, citalopram, and donepezil, although certain signs also worsened." | 3.76 | Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. ( Greenway, LL; Kuppuswamy, PS; Lauterbach, EC, 2010) |
"We encountered catatonia in a man with neurosyphilis after increasing aripiprazole and valproate (drugs reported to improve catatonia) and reducing doxycycline and temazepam dosages, consistent with identified dopamine D2, serotonin 5HT2, and 5HT1a (aripiprazole), GABA-B (valproate), glutamatergic NMDA (aripiprazole, valproate, doxycycline), and GABA-A (aripiprazole, temazepam) mechanisms of catatonia." | 3.75 | Catatonia and CPK elevation in neurosyphilis: role of plural pharmacodynamic mechanisms. ( Carter, WG; Lauterbach, EC; Norris, BK; Shillcutt, SD, 2009) |
" Hyperactivity, impulsivity, and inattention improved with lorazepam, suggesting that the attention-deficit/hyperactivity disorder symptoms could be manifestations of catatonia." | 3.73 | PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. ( Ahmed, AA; Balamuth, N; Dell, ML; Elia, J; Friedman, DF; Pati, S; Zimmerman, RA, 2005) |
"The authors describe four cases of catatonia in which topiramate treatment was used." | 3.73 | Topiramate effect in catatonia: a case series. ( McDaniel, WW; Sahota, AK; Spiegel, DR, 2006) |
" The speech catatonic symptoms, previously refractory to various antipsychotics, responded promptly to lorazepam, a benzodiazepine with documented efficacy in the treatment of acute catatonia but not chronic catatonia." | 3.72 | Chronic 'speech catatonia' with constant logorrhea, verbigeration and echolalia successfully treated with lorazepam: a case report. ( Lee, JW, 2004) |
"Acute catatonia of the retarded type responds rapidly to treatment with lorazepam." | 3.69 | Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. ( Gaind, GS; Mazurek, MF; Rosebush, PI, 1994) |
"The case history of a patient with presumed psychogenic catatonia who responded dramatically to two mg of IM lorazepam is presented." | 3.67 | Benzodiazepines and catatonia: a case report. ( Harris, D; Menza, MA, 1989) |
" Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 3.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
"Lorazepam was successfully used, along with electroconvulsive therapy, antipsychotics, and other treatments." | 3.01 | COVID-19 and catatonia: Prevalence, challenges, pathophysiology, and treatment. ( Koola, MM; Mohammadi, T; Oh, J; Pradhan, BK; Sahota, PC, 2023) |
"Lorazepam was initiated but did not control the catatonic symptoms." | 3.01 | Catatonia as the Presentation of Encephalopathy Associated With Autoimmune Thyroiditis: A Case Report and Literature Review. ( Al-Ghannami, AK; Ali, HT; Caprara, ALF; Mohamed, FR; Rissardo, JP, 2023) |
"Lorazepam was ineffective at reversing his catatonic symptoms, and his serum creatinine kinase level eventually began to rise, suggestive of muscle breakdown and worsening severity." | 2.72 | Electroconvulsive therapy use in the adult U.S. correctional setting: A case report and literature review. ( Martin, M; Ureste, P, 2021) |
"Lorazepam 1 to 2 mg was administered in every case, and patients were evaluated at hourly intervals." | 2.67 | Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. ( Furlong, BG; Hildebrand, AM; Mazurek, MF; Rosebush, PI, 1990) |
"Catatonia was first described by Karl Ludwig Kahlbaum in 1874, occurring in association with other psychiatric and medical disorders." | 2.66 | Catatonia in Patients with Autism Spectrum Disorder. ( Andersen, L; Ghaziuddin, M; Ghaziuddin, N, 2020) |
"Catatonia has been increasingly recognized in people with autism spectrum disorders (ASD)." | 2.61 | Electroconvulsive Treatment for Catatonia in Autism Spectrum Disorders. ( Dhossche, DM; Withane, N, 2019) |
"Pediatric catatonia is believed to be a rare condition, but challenges in recognition and variability in presentation may lead to underdiagnosis." | 2.58 | Pediatric Catatonia: A Case Series-Based Review of Presentation, Evaluation, and Management. ( Chaney-Catchpole, M; Hazen, EP; Sorg, EM, 2018) |
"Concerning the management of catatonia in patients with schizophrenia, for whom first-line benzodiazepines are often insufficient, certain atypical antipsychotics such as clozapine or quetiapine appear efficient." | 2.53 | Catatonic syndrome: From detection to therapy. ( Callery, G; Dollfus, S; Lebain, P; Madigand, J, 2016) |
"To review catatonia in autism spectrum disorders." | 2.52 | [Catatonia in autism spectrum disorders: review and case-report]. ( Dhossche, DM; Shettar, SM; van der Steen, LF, 2015) |
"The diagnosis and management of catatonia in the critically ill patient raises unique challenges." | 2.50 | Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. a case series and review of the literature*. ( Berg, SM; Bittner, EA; Nejad, SH; Saddawi-Konefka, D, 2014) |
"A search for deep vein thrombosis/pulmonary embolism guidelines yielded 478 articles that were appraised for relevance, and 6 were chosen for review; the pressure ulcer guideline search yielded 5,665 articles, and 5 were chosen; the muscle contractures guideline search yielded 1,481 articles, and 3 were chosen; and the nutritional deficiencies guideline search yielded 16,937 articles, and 4 were chosen." | 2.50 | Guidelines for preventing common medical complications of catatonia: case report and literature review. ( Azzam, PN; Clinebell, K; Gopalan, P; Haskett, R, 2014) |
"Catatonia is often a prominent feature of the syndrome." | 2.49 | Delirious mania: detection, diagnosis, and clinical management in the acute setting. ( Bobo, WV; Heckers, S; Jacobowski, NL, 2013) |
"He understood catatonia as a disease of its own." | 2.46 | Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. ( Fink, M; Shorter, E; Taylor, MA, 2010) |
"Catatonia is a distinct neuropsychiatric syndrome that is becoming more recognized clinically and in ongoing research." | 2.46 | Catatonia: diagnosis, classification, and treatment. ( Francis, A, 2010) |
"The authors identified 25 cases of catatonia treated with either agent." | 2.44 | Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. ( Ahuja, N; Carroll, BT; Franco, KN; Goforth, HW; Kraus, MF; McDaniel, WW; Muñoz, C; Pozuelo, L; Spiegel, DR; Thomas, C, 2007) |
"There is increasing evidence that catatonia is an important source of impairment in adolescents and adults with autism." | 2.44 | Catatonia in autism: implications across the life span. ( Dhossche, DM; Kakooza-Mwesige, A; Wachtel, LE, 2008) |
"Since almost all descriptions of autism highlight the presence of motor symptoms that characterize catatonia, an assessment for this eminently treatable syndrome is recommended for all patients considered to be autistic." | 2.43 | Catatonia in autistic spectrum disorders: a medical treatment algorithm. ( Fink, M; Ghaziuddin, N; Taylor, MA, 2006) |
"In the first, catatonia was described as an under-recognized syndrome with a potentially fatal outcome." | 2.40 | Catatonia. 2: Diagnosis, management and prognosis. ( Clark, T; Rickards, H, 1999) |
"The authors report five new cases of catatonia; three patients responded favorably and two failed to respond to lorazepam." | 2.37 | Lorazepam treatment of psychogenic catatonia: an update. ( Kilzieh, N; Salam, SA, 1988) |
"benzodiazepines; case reports; catatonia; electroconvulsive therapy." | 1.91 | Resistant Catatonia in a 10-year-old Child: A Case Report. ( Jha, A, 2023) |
"Baclofen was approved for medical use in the United States in 1977 by Food and Drug Administration." | 1.72 | Baclofen and catatonia: a case report. ( Caprara, ALF; Gadamidi, VK; Konduru, SN; Rissardo, JP, 2022) |
" It offers future studies direction for standardizing lorazepam dosing schedules for catatonia management and exploring neurobiological underpinnings for individual catatonic signs that may be potentially different, given these findings." | 1.62 | Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting. ( Aandi Subramaniyam, B; Muliyala, KP; Reddi, VSK; Suchandra, HH, 2021) |
"Catatonia is a clinical syndrome characterized by psychomotor disruption, which often goes undiagnosed." | 1.62 | Refractory catatonia in old age: a case report. ( Amin, J; Bean, E; Findlay, C; Gee, C, 2021) |
"Treatment with lorazepam led to improvement in symptoms in all, eventually reversing the catatonia in some children to previous baseline function." | 1.56 | Catatonia as a feature of down syndrome: An under-recognised entity? ( Allen, NM; Cahalane, D; Flanagan, O; Lyons, A, 2020) |
"Catatonia is a severe neuropsychiatric syndrome with an excellent prognosis if recognized and treated without delay." | 1.51 | Catatonia in patients with dementia: a case report. ( Khouadja, S; Younes, S; Zarrouk, L, 2019) |
"He was diagnosed with catatonia and treated successfully with lorazepam." | 1.51 | Temporal glioblastoma presenting as catatonia. ( Franssen, A; Sienaert, P, 2019) |
"CASE REPORT We present 2 cases of catatonia diagnosed in liver allograft recipients." | 1.48 | Catatonia After Liver Transplantation. ( Kozlowski, T; Laughon, SL; Tatreau, JR, 2018) |
"Attribution of catatonia to a psychiatric etiology was associated with significantly less diagnostic workup." | 1.46 | Suspected Delirium Predicts the Thoroughness of Catatonia Evaluation. ( Coffey, MJ; Cooper, JJ; Jacobson, KC; Llesuy, JR, 2017) |
"Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient." | 1.46 | Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. ( Duncan-Azadi, CR; Gormley, A; Johnson, PN, 2017) |
"Catatonia is a severe motor syndrome found in approximately 10% of all acute psychiatric hospital admissions." | 1.43 | Catatonia and cannabis withdrawal: A case report. ( Amad, A; Caudron, M; Deheul, S; Geoffroy, PA; Rolland, B; Thomas, P, 2016) |
"Catatonia is a common but often overlooked motor syndrome in child and adolescent psychiatry." | 1.43 | [Catatonia is often overlooked in child and adolescent psychiatry]. ( Ballin, NH; Pagsberg, AK, 2016) |
"Although catatonia is often associated with psychiatric disorders such as schizophrenia or depression, in about 20 to 39% of the patients a somatic illness is found." | 1.43 | Dexamethasone-induced catatonia in a patient with multiple myeloma. ( Lemmens, G; Vanstechelman, S; Vantilborgh, A, 2016) |
"Studies in major depressive disorder have demonstrated that suprathreshold, nondominant (right) hemisphere, unilateral electrode placement ECT has fewer adverse effects, especially cognitive adverse effects, than bitemporal ECT." | 1.40 | Successful use of right unilateral ECT for catatonia: a case series. ( Conway, C; Cristancho, P; Jewkes, D; Mon, T, 2014) |
"We report a case of late-onset catatonia associated with enlarged CSP and cavum vergae." | 1.39 | Cavum septum pellucidum and cavum vergae with late-onset catatonia. ( Amano, N; Hanihara, T; Takahashi, T; Takahashi, Y; Washizuka, S; Yasaki, T, 2013) |
"Our case demonstrates that catatonia can follow minor traumatic injury and how excited-type catatonic features may go unrecognised in general practitioner and specialist settings." | 1.39 | Agitation after minor trauma: combativeness as a cardinal catatonic feature. ( Luykx, JJ; Post, EH; van der Erf, M; Van Hecke, J, 2013) |
"Although neurological manifestations of typhoid fever was thought to be obsolete from modern world, emergence of multidrug resistant typhoid bacilli and reporting of outbreak of typhoid fever with a range of early neuropsychiatric manifestations from various parts of world has led clinicians and investigators to re-evaluate the clinical spectrum of this endemic sinister disease." | 1.39 | Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience. ( Dutta, A; Rana, S; Talukdar, A; Talukdar, P, 2013) |
"The diagnostic criteria of catatonia and frontotemporal dementia partly overlap." | 1.39 | Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy. ( Arai, H; Iseki, E; Utumi, Y, 2013) |
"Catatonia is a rare manifestation of benzodiazepine withdrawal in elderly patients who have used it for a long time." | 1.39 | Lorazepam withdrawal catatonia: a case report. ( Khandelwal, SK; Sivakumar, T; Sood, M; Yadav, A, 2013) |
"We present a case of catatonia associated with hyponatremia treated with a course of electroconvulsive therapy." | 1.38 | Catatonia associated with hyponatremia treated with electroconvulsive therapy. ( Aggarwal, M; Grover, S; Kattharaghatta Girigowda, V; Malhotra, N, 2012) |
"Catatonia is a well-described neuropsychiatric syndrome that has been the subject of several texts." | 1.37 | Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn. ( Aloysi, AS; Kellner, CH; Popeo, DM, 2011) |
"A 76-year-old woman presented with catatonia, refusal to eat due to delusion, and visual hallucination." | 1.37 | Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. ( Maeda, K; Ogawa, N, 2011) |
"We describe an unusual presentation of catatonia in a female patient with schizoaffective disorder." | 1.37 | An unusual presentation of catatonia in a patient with schizoaffective disorder. ( Liang, CS; Liao, WC; Yang, FW, 2011) |
"Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 1.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
"We recommend being alert for catatonia in patients with or without a psychiatric disorder." | 1.36 | [Catatonia]. ( Blom, JD; Bruijn, DJ, 2010) |
"Malignant catatonia is a severe form of catatonia which is acute in onset, and is systemically devastating, as it is associated with fever and autonomic instability." | 1.35 | Electroconvulsive therapy for malignant catatonia in adolescence. ( Burt, L; Dhossche, DM; Kumar, T; Shettar, SM, 2009) |
" We treated catatonic symptoms with drugs within the upper limit of dosage and electroconvulsive therapy (ECT) to determine the maximal response." | 1.34 | Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. ( Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C, 2007) |
"Psychosis and auditory hallucinations are characteristic features of schizophrenia, but may also complicate many somatic diseases." | 1.34 | A vanishing lesion in the temporal lobe associated with schizophrenialike psychosis and catatonia. ( Beerepoot, LJ; Kho, KH; Sommer, IE; van Veelen, NM, 2007) |
" In the specific case of acute catatonia brought on by benzodiazepine withdrawal the recommended dosage is the same as for acute catatonia caused by something other than benzodiazepine withdrawal." | 1.33 | [Benzodiazepines in the treatment of catatonia]. ( Sabbe, BG; Van Dalfsen, AN; Van Den Bossche, B; Van Den Eede, F, 2006) |
"However, there are rare cases of catatonia being described in SLE." | 1.33 | Benzodiazepines in catatonia associated with systemic lupus erythematosus. ( Huang, TL; Wang, HY, 2006) |
"Treatment and course of catatonia in an adolescent patient with Prader-Willi Syndrome are presented." | 1.30 | Catatonia in an adolescent with Prader-Willi Syndrome. ( Bouman, NH; Dhossche, DM, 1997) |
"Lethal catatonia (LC) is a life-threatening neuropsychiatric syndrome associated with a host of psychiatric, neurologic and medical conditions." | 1.29 | The syndrome of lethal catatonia. ( Leung, CM; Leung, WK; Tang, CP; Ungvari, GS, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (6.74) | 18.7374 |
1990's | 32 (16.58) | 18.2507 |
2000's | 29 (15.03) | 29.6817 |
2010's | 87 (45.08) | 24.3611 |
2020's | 32 (16.58) | 2.80 |
Authors | Studies |
---|---|
Kompella, S | 1 |
Gallucci, F | 1 |
Jones, S | 1 |
Ikekwere, J | 1 |
Poulsen, R | 2 |
Parker, J | 1 |
Coffey, BJ | 4 |
Nikjoo, A | 1 |
Wright, C | 1 |
Kheriaty, A | 1 |
Rathinakumar, H | 1 |
Schutz, C | 1 |
Smith, R | 1 |
French, BR | 1 |
Mhadi, E | 1 |
Brandt, K | 1 |
Marr, MC | 1 |
Staropoli, M | 1 |
Bonney, P | 1 |
Chien, J | 1 |
Tiwari, S | 1 |
Akyuz, E | 1 |
Das, A | 1 |
Spiegel, DR | 4 |
Ayzman, A | 1 |
Reid, FE | 1 |
Ahuja, K | 1 |
Worfolk, J | 1 |
Valerstain, D | 1 |
Zaydlin, M | 1 |
Bez, Y | 1 |
Laurin, A | 1 |
Capelle, N | 1 |
Bukowski, N | 1 |
Le Page, A | 1 |
Gendre, I | 1 |
Sauvaget, A | 1 |
Bulteau, S | 1 |
Naguy, A | 1 |
Alamiri, B | 1 |
Rissardo, JP | 2 |
Konduru, SN | 1 |
Gadamidi, VK | 1 |
Caprara, ALF | 2 |
Oh, J | 1 |
Sahota, PC | 1 |
Mohammadi, T | 1 |
Pradhan, BK | 1 |
Koola, MM | 1 |
Gauthier, T | 1 |
Prakash, PB | 1 |
Keopple, D | 1 |
Vardis, R | 1 |
Jha, A | 1 |
Slavnic, B | 1 |
Barnett, BS | 1 |
McIntire, S | 1 |
Becker, R | 1 |
Saba, S | 1 |
Vellanki, KD | 1 |
Honaker, L | 1 |
Weleff, J | 1 |
Carroll, BT | 5 |
Ali, HT | 1 |
Mohamed, FR | 1 |
Al-Ghannami, AK | 1 |
Abramov, M | 1 |
Mahgoub, YO | 1 |
Younes, S | 2 |
Khouadja, S | 1 |
Zarrouk, L | 1 |
Fernandez, A | 1 |
Pendaries, G | 1 |
Dor, E | 1 |
Askenazy, F | 1 |
Thümmler, S | 1 |
Sikavi, D | 1 |
McMahon, J | 1 |
Fromson, JA | 1 |
Chatterjee, SS | 1 |
Mitra, S | 1 |
Khonglah, D | 1 |
Singh, OP | 1 |
Lyons, A | 1 |
Allen, NM | 1 |
Flanagan, O | 1 |
Cahalane, D | 1 |
Mustafa, FA | 1 |
Nayar, A | 1 |
Ghaziuddin, N | 2 |
Andersen, L | 1 |
Ghaziuddin, M | 1 |
Gouse, BM | 1 |
Spears, WE | 1 |
Nieves Archibald, A | 1 |
Montalvo, C | 1 |
Fernández-Sotos, P | 1 |
López-Álvarez, J | 1 |
López Arcas-Calleja, P | 1 |
García-Tercero, RM | 1 |
Del Yerro-Álvarez, MJ | 1 |
Suchandra, HH | 1 |
Reddi, VSK | 1 |
Aandi Subramaniyam, B | 1 |
Muliyala, KP | 1 |
Martin, M | 1 |
Ureste, P | 1 |
Shrivastava, SVK | 1 |
Mavrides, N | 1 |
Kaur, M | 1 |
Floyd, AE | 1 |
Faisal, M | 1 |
Pradeep, V | 1 |
O'Hanrahan, S | 1 |
Smith, S | 1 |
Ketheesan, S | 1 |
Touma, E | 1 |
Lipman, J | 1 |
Brown, AF | 1 |
Barger, A | 1 |
Monter, E | 1 |
de Neeling, M | 1 |
van Paesschen, W | 1 |
Bean, E | 1 |
Findlay, C | 1 |
Gee, C | 1 |
Amin, J | 1 |
Rice, T | 1 |
Crow, M | 1 |
Cardieri, B | 1 |
Acheampong, D | 1 |
Unal, A | 2 |
Altindag, A | 1 |
Demir, B | 1 |
Aksoy, I | 1 |
Kar, SK | 2 |
Srivastava, A | 1 |
Ali, SF | 1 |
Gowda, GS | 1 |
Jaisoorya, TS | 1 |
Math, SB | 2 |
Agrawal, AK | 1 |
Das, S | 1 |
George, R | 1 |
Langford, A | 1 |
Cevher Binici, N | 1 |
Topal, Z | 1 |
Demir Samurcu, N | 1 |
Cansız, MA | 1 |
Savcı, U | 1 |
Öztürk, Y | 1 |
Özyurt, G | 1 |
Tufan, AE | 1 |
Denysenko, L | 1 |
Sica, N | 1 |
Penders, TM | 1 |
Philbrick, KL | 1 |
Walker, A | 1 |
Shaffer, S | 1 |
Zimbrean, P | 1 |
Freudenreich, O | 1 |
Rex, N | 1 |
Francis, A | 5 |
Wahidi, N | 1 |
de Leon, J | 1 |
Sorg, EM | 1 |
Chaney-Catchpole, M | 1 |
Hazen, EP | 1 |
Ratzlaff, M | 1 |
Harrington, M | 1 |
Tatreau, JR | 1 |
Laughon, SL | 1 |
Kozlowski, T | 1 |
Verbraeken, R | 1 |
Luykx, JJ | 2 |
Leroy, A | 1 |
Corfiotti, C | 1 |
Nguyen The Tich, S | 1 |
Ferrafiat, V | 1 |
Amad, A | 2 |
Jardri, R | 1 |
Medjkane, F | 1 |
Withane, N | 1 |
Dhossche, DM | 7 |
Iyengar, S | 1 |
Bornmann, C | 1 |
Abdelmalak, F | 1 |
LaRocca, T | 1 |
Buell, KG | 1 |
Kiser, SB | 1 |
Vasilevskis, EE | 1 |
Franssen, A | 1 |
Sienaert, P | 1 |
Bülbül, F | 1 |
Çöpoğlu, ÜS | 1 |
Alpak, G | 1 |
Savaş, HA | 1 |
Saxena, S | 1 |
Trivedi, JK | 1 |
Chung, I | 1 |
Weber, GM | 1 |
Cuffy, MC | 1 |
Vedula, G | 1 |
Samstein, B | 1 |
Moitra, VK | 1 |
Yasaki, T | 1 |
Takahashi, Y | 1 |
Takahashi, T | 1 |
Washizuka, S | 1 |
Amano, N | 1 |
Hanihara, T | 1 |
Grover, S | 2 |
Parakh, P | 1 |
Sharma, A | 1 |
Rao, P | 1 |
Modi, M | 1 |
Kumar, A | 1 |
Post, EH | 1 |
van der Erf, M | 1 |
Van Hecke, J | 1 |
Talukdar, P | 1 |
Dutta, A | 1 |
Rana, S | 1 |
Talukdar, A | 1 |
Lin, CC | 3 |
Huang, TL | 7 |
Quinn, DK | 1 |
Rees, C | 1 |
Brodsky, A | 1 |
Deligtisch, A | 1 |
Evans, D | 1 |
Khafaja, M | 1 |
Abbott, CC | 1 |
Cristancho, P | 1 |
Jewkes, D | 1 |
Mon, T | 1 |
Conway, C | 1 |
Singh, LK | 1 |
Praharaj, SK | 1 |
Utumi, Y | 1 |
Iseki, E | 1 |
Arai, H | 2 |
Saddawi-Konefka, D | 2 |
Berg, SM | 2 |
Nejad, SH | 2 |
Bittner, EA | 2 |
Sivakumar, T | 1 |
Yadav, A | 1 |
Sood, M | 1 |
Khandelwal, SK | 1 |
Young, GB | 1 |
Adams, G | 1 |
Brown, A | 1 |
Burnside, A | 1 |
Tanday, R | 1 |
Lowe, D | 1 |
Li, K | 1 |
Malhotra, PA | 1 |
Falinska, A | 1 |
Coker, R | 1 |
Ind, P | 1 |
Waheed, U | 1 |
Broomhead, R | 1 |
Bassett, JH | 1 |
Sam, AH | 1 |
Smith, DL | 1 |
Roberts, C | 1 |
Clinebell, K | 1 |
Azzam, PN | 1 |
Gopalan, P | 1 |
Haskett, R | 1 |
Ungvari, GS | 5 |
Rizos, DV | 1 |
Peritogiannis, V | 1 |
van der Steen, LF | 1 |
Shettar, SM | 2 |
Barnhorst, A | 1 |
Xiong, GL | 1 |
Caudron, M | 1 |
Rolland, B | 1 |
Deheul, S | 1 |
Geoffroy, PA | 1 |
Thomas, P | 1 |
Dhossche, D | 3 |
Kellner, CH | 2 |
Matias, DF | 1 |
Ando, Sde M | 1 |
Riera, R | 1 |
Góis, AF | 1 |
van der Markt, A | 1 |
Heller, HM | 1 |
van Exel, E | 1 |
Kakooza-Mwesige, A | 2 |
Idro, R | 1 |
Akena, D | 1 |
Nalugya, J | 1 |
Opar, BT | 1 |
Ballin, NH | 1 |
Pagsberg, AK | 1 |
Hung, YY | 3 |
Tsai, MC | 3 |
Vanstechelman, S | 1 |
Vantilborgh, A | 1 |
Lemmens, G | 1 |
Khalafian, A | 1 |
Dukes, C | 1 |
Tucker, P | 1 |
Madigand, J | 1 |
Lebain, P | 1 |
Callery, G | 1 |
Dollfus, S | 1 |
Low, DA | 1 |
Xu, J | 1 |
Tibrewal, P | 2 |
Bastiampillai, T | 2 |
Dhillon, R | 1 |
Koychev, I | 1 |
Hadjiphilippou, S | 1 |
Lynch, J | 1 |
Whelan, P | 1 |
MacCabe, J | 1 |
Thamizh, JS | 1 |
Harshini, M | 1 |
Selvakumar, N | 1 |
Bharadwaj, B | 1 |
Menon, V | 1 |
Llesuy, JR | 1 |
Coffey, MJ | 2 |
Jacobson, KC | 1 |
Cooper, JJ | 1 |
Villamil, EA | 1 |
Gonzalez, R | 1 |
Duncan-Azadi, CR | 1 |
Johnson, PN | 1 |
Gormley, A | 1 |
Alisky, JM | 2 |
Massengale, J | 1 |
Tafti, BA | 1 |
Large, L | 1 |
Skirboll, S | 1 |
Fink, M | 5 |
Shorter, E | 2 |
Taylor, MA | 3 |
Kumar, T | 1 |
Burt, L | 1 |
Richter, A | 1 |
Grimm, S | 1 |
Northoff, G | 4 |
Manjunatha, N | 1 |
Mehta, UM | 1 |
John, P | 1 |
Lauterbach, EC | 2 |
Norris, BK | 1 |
Carter, WG | 1 |
Shillcutt, SD | 1 |
Malur, C | 1 |
Clark, A | 1 |
Krähenmann, R | 1 |
Küchenhoff, B | 1 |
Böker, H | 1 |
Schick, M | 1 |
Narayanaswamy, J | 1 |
Zutshi, A | 1 |
Srinivasaraju, R | 1 |
Kuppuswamy, PS | 1 |
Greenway, LL | 1 |
Enterman, JH | 1 |
van Dijk, D | 1 |
Consoli, A | 1 |
Gheorghiev, C | 1 |
Jutard, C | 1 |
Bodeau, N | 1 |
Kloeckner, A | 1 |
Pitron, V | 1 |
Cohen, D | 1 |
Bonnot, O | 1 |
Bruijn, DJ | 1 |
Blom, JD | 1 |
Danivas, V | 1 |
Behere, RV | 2 |
Varambally, S | 2 |
Rao, NP | 2 |
Venkatasubramanian, G | 2 |
Gangadhar, BN | 2 |
Aloysi, AS | 1 |
Popeo, DM | 1 |
Narayanaswamy, JC | 1 |
Viswanath, B | 1 |
Jose, SP | 1 |
Chakraborty, V | 1 |
Subodh, BN | 1 |
Benegal, V | 1 |
Maeda, K | 1 |
Ogawa, N | 1 |
Wachtel, LE | 2 |
Mutalik, NR | 1 |
Kasal, V | 1 |
Liang, CS | 1 |
Yang, FW | 1 |
Liao, WC | 1 |
Grenier, E | 1 |
Ryan, M | 1 |
Ko, E | 1 |
Fajardo, K | 1 |
John, V | 1 |
Wang, BZ | 1 |
Gupta, A | 1 |
Sani, F | 1 |
Amos, JJ | 1 |
Mukai, Y | 1 |
Two, A | 1 |
Jean-Baptiste, M | 1 |
Kattharaghatta Girigowda, V | 1 |
Aggarwal, M | 1 |
Malhotra, N | 1 |
Makhinson, M | 1 |
Furst, BA | 1 |
Shuff, MK | 1 |
Kwon, GE | 1 |
Rodriguez, E | 1 |
Wells, M | 1 |
Jacobowski, NL | 1 |
Heckers, S | 1 |
Bobo, WV | 1 |
Bostwick, JM | 1 |
Chozinski, JP | 1 |
Lai, JY | 1 |
Niedermier, JA | 1 |
Lee, JW | 3 |
Huffman, JC | 1 |
Fricchione, GL | 2 |
Elia, J | 1 |
Dell, ML | 1 |
Friedman, DF | 1 |
Zimmerman, RA | 1 |
Balamuth, N | 1 |
Ahmed, AA | 1 |
Pati, S | 1 |
Pruett, JR | 1 |
Rizvi, ST | 1 |
McDaniel, WW | 2 |
Sahota, AK | 1 |
Van Dalfsen, AN | 1 |
Van Den Eede, F | 1 |
Van Den Bossche, B | 1 |
Sabbe, BG | 1 |
Wang, HY | 1 |
Balhara, Y | 1 |
de Winter, CF | 1 |
van Dijk, F | 1 |
Verhoeven, WM | 1 |
Stolker, JJ | 1 |
Goforth, HW | 2 |
Thomas, C | 2 |
Ahuja, N | 2 |
Kraus, MF | 1 |
Franco, KN | 1 |
Pozuelo, L | 1 |
Muñoz, C | 1 |
Tugrul, KC | 1 |
Coconcea, C | 1 |
Hatta, K | 1 |
Miyakawa, K | 1 |
Ota, T | 1 |
Usui, C | 1 |
Nakamura, H | 1 |
Kho, KH | 1 |
van Veelen, NM | 1 |
Beerepoot, LJ | 1 |
Sommer, IE | 1 |
Singh, D | 1 |
Forlano, R | 1 |
Athey, R | 1 |
Cassem, NH | 1 |
Hooberman, D | 1 |
Hobson, D | 1 |
Singerman, B | 1 |
Raheja, R | 1 |
Leung, HC | 1 |
Lee, TS | 1 |
Leung, CM | 2 |
Wong, MK | 1 |
Lau, J | 1 |
Marneros, A | 1 |
Jäger, A | 1 |
Gaind, GS | 1 |
Rosebush, PI | 4 |
Mazurek, MF | 3 |
Lee, WY | 1 |
Joseph, WY | 1 |
Bush, G | 2 |
Petrides, G | 3 |
Dowling, F | 1 |
Wenke, J | 2 |
Pflug, B | 2 |
Yeung, PP | 1 |
Milstein, RM | 1 |
Daniels, DC | 1 |
Bowers, MB | 2 |
Demisch, L | 1 |
Eckert, J | 1 |
Gille, B | 1 |
Tang, CP | 1 |
Leung, WK | 1 |
Divadeenam, KM | 2 |
Schwartz, DL | 1 |
Bouman, NH | 1 |
Armstrong, SC | 1 |
Koek, RJ | 1 |
Mervis, JR | 1 |
Rosenfeld, MJ | 1 |
Friedman, JH | 1 |
Chiu, HF | 1 |
Chow, LY | 1 |
Lau, BS | 1 |
Tang, WK | 1 |
Schmider, J | 1 |
Standhart, H | 1 |
Deuschle, M | 1 |
Drancoli, J | 1 |
Heuser, I | 2 |
Clark, T | 1 |
Rickards, H | 1 |
Pfennig, A | 1 |
Krug, M | 1 |
Danos, P | 1 |
Leschinger, A | 1 |
Schwarz, A | 1 |
Bogerts, B | 1 |
Kritzinger, PR | 1 |
Jordaan, GP | 1 |
Woodbury, MM | 1 |
Woodbury, MA | 1 |
Scamvougeras, A | 1 |
Weller, M | 1 |
Hildebrand, AM | 2 |
Chandler, JD | 1 |
Menza, MA | 2 |
Furlong, BG | 1 |
Yassa, R | 1 |
Iskandar, H | 1 |
Lalinec, M | 1 |
Cleto, L | 1 |
Ungvari, GA | 1 |
Rankin, JF | 1 |
Harris, D | 1 |
Wetzel, H | 2 |
Benkert, O | 2 |
Salam, SA | 2 |
Kilzieh, N | 1 |
Ripley, TL | 1 |
Millson, RC | 1 |
Pillai, AK | 1 |
Beresford, TP | 1 |
Greenfeld, D | 1 |
Conrad, C | 1 |
Kincare, P | 1 |
Casey, DA | 1 |
Vinogradov, S | 1 |
Reiss, AL | 1 |
Peterson, GN | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Catatonia in Ugandan Children With Nodding Syndrome and Effects of Treatment With Lorazepam: A Pilot Study[NCT02462109] | Phase 1 | 16 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
"Interventional Triple-negative Placebo-controlled Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia"[NCT06176456] | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
27 reviews available for lorazepam and Catatonia
Article | Year |
---|---|
COVID-19 and catatonia: Prevalence, challenges, pathophysiology, and treatment.
Topics: Catatonia; COVID-19; Electroconvulsive Therapy; Humans; Lorazepam; Mental Disorders; Prevalence | 2023 |
Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020.
Topics: Catatonia; Central Nervous System Stimulants; Humans; Lorazepam; Methamphetamine; Research | 2023 |
Catatonia as the Presentation of Encephalopathy Associated With Autoimmune Thyroiditis: A Case Report and Literature Review.
Topics: Brain Diseases; Catatonia; Female; Hashimoto Disease; Humans; Lorazepam; Middle Aged; Thyroiditis, A | 2023 |
Catatonia Due to Tacrolimus Toxicity 16 Years After Renal Transplantation: Case Report and Literature Review.
Topics: Aged; Antipsychotic Agents; Catatonia; Cyclosporine; Electroencephalography; Female; GABA Modulators | 2019 |
Catatonia in Patients with Autism Spectrum Disorder.
Topics: Anticonvulsants; Autism Spectrum Disorder; Benzodiazepines; Catatonia; Electroconvulsive Therapy; Hu | 2020 |
Electroconvulsive therapy use in the adult U.S. correctional setting: A case report and literature review.
Topics: Bipolar Disorder; Catatonia; Creatine Kinase; Electroconvulsive Therapy; Health Services Accessibili | 2021 |
Catatonia in the medically ill: Etiology, diagnosis, and treatment. The Academy of Consultation-Liaison Psychiatry Evidence-Based Medicine Subcommittee Monograph.
Topics: Antipsychotic Agents; Benzodiazepines; Catatonia; Electroconvulsive Therapy; Humans; Lorazepam | 2018 |
Pediatric Catatonia: A Case Series-Based Review of Presentation, Evaluation, and Management.
Topics: Adolescent; Catatonia; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Lorazepam; Male | 2018 |
Persistent catatonia following epileptic seizures: a case report and systematic literature search.
Topics: Adult; Anticonvulsants; Catatonia; Humans; Lorazepam; Male; Seizures | 2018 |
Electroconvulsive Treatment for Catatonia in Autism Spectrum Disorders.
Topics: Adolescent; Adolescent Psychiatry; Autism Spectrum Disorder; Benzodiazepines; Catatonia; Electroconv | 2019 |
Catatonia in systemic lupus erythematosus: a case report and review of literature.
Topics: Anti-Anxiety Agents; Catatonia; Female; Follow-Up Studies; Humans; Lorazepam; Lupus Erythematosus, S | 2013 |
Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. a case series and review of the literature*.
Topics: Adolescent; Aged; Anti-Anxiety Agents; Blood Chemical Analysis; Catatonia; Critical Illness; Early D | 2014 |
Guidelines for preventing common medical complications of catatonia: case report and literature review.
Topics: Aged; Catatonia; Combined Modality Therapy; Contracture; Cooperative Behavior; Electroconvulsive The | 2014 |
Catatonia in DSM 5: controversies regarding its psychopathology, clinical presentation and treatment response.
Topics: Antipsychotic Agents; Benzodiazepines; Catatonia; Clinical Trials as Topic; Concept Formation; Diagn | 2014 |
[Catatonia in autism spectrum disorders: review and case-report].
Topics: Anticonvulsants; Benzodiazepines; Catatonia; Child; Child Development Disorders, Pervasive; Comorbid | 2015 |
Catatonic syndrome: From detection to therapy.
Topics: Adolescent; Adult; Catatonia; Child; Humans; Hypnotics and Sedatives; Lorazepam; Psychiatric Status | 2016 |
Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature.
Topics: Anti-Anxiety Agents; Catatonia; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental | 2010 |
Catatonia: diagnosis, classification, and treatment.
Topics: Anticonvulsants; Catatonia; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Dis | 2010 |
Delirious mania: detection, diagnosis, and clinical management in the acute setting.
Topics: Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Humans; Hypnotics and Sedatives; L | 2013 |
Catatonia in autistic spectrum disorders: a medical treatment algorithm.
Topics: Adolescent; Algorithms; Anticonvulsants; Autistic Disorder; Catatonia; Electroconvulsive Therapy; Fe | 2006 |
[Autism and catatonia: successful treatment using lorazepam. A case study].
Topics: Adult; Autistic Disorder; Catatonia; Humans; Hypnotics and Sedatives; Lorazepam; Male; Treatment Out | 2007 |
Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes.
Topics: Catatonia; Clinical Trials as Topic; Electroconvulsive Therapy; Excitatory Amino Acid Antagonists; G | 2007 |
Catatonia in autism: implications across the life span.
Topics: Adolescent; Adult; Algorithms; Autistic Disorder; Benzodiazepines; Catatonia; Child; Comorbidity; Di | 2008 |
Malignant catatonia--a continuing reality.
Topics: Adult; Aged; Antipsychotic Agents; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; El | 1994 |
Catatonia. 2: Diagnosis, management and prognosis.
Topics: Benzodiazepines; Catatonia; Diagnosis, Differential; Electroconvulsive Therapy; Humans; Hypnotics an | 1999 |
Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
Topics: Adolescent; Catatonia; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Neuroleptic | 1992 |
Lorazepam treatment of psychogenic catatonia: an update.
Topics: Adult; Aged; Anemia, Pernicious; Catatonia; Female; Humans; Lorazepam; Male; Middle Aged; Pregnancy; | 1988 |
10 trials available for lorazepam and Catatonia
Article | Year |
---|---|
Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis.
Topics: Anti-Anxiety Agents; Catatonia; Clinical Protocols; Diazepam; Drug Therapy, Combination; Humans; Lor | 2013 |
Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study.
Topics: Adolescent; Adult; Anticonvulsants; Catatonia; Child; Female; Humans; Lorazepam; Male; Nodding Syndr | 2015 |
Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia.
Topics: Adult; Analysis of Variance; Anticonvulsants; Brain Mapping; Catatonia; Emotions; Female; Humans; Im | 2010 |
Lorazepam and diazepam for relieving catatonic features in multiple sclerosis.
Topics: Adult; Catatonia; Diazepam; Drug Therapy, Combination; Electroshock; Female; Humans; Hypnotics and S | 2007 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia.
Topics: Adolescent; Adult; Anesthesia; Catatonia; Combined Modality Therapy; Electroconvulsive Therapy; Fema | 1997 |
Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.
Topics: Adult; Aged; Anti-Anxiety Agents; Catatonia; Chronic Disease; Cross-Over Studies; Double-Blind Metho | 1999 |
A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism.
Topics: Adult; Aged; Anti-Anxiety Agents; Brief Psychiatric Rating Scale; Catatonia; Cross-Over Studies; Dos | 1999 |
Catatonia: an open prospective series with carbamazepine.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Carbamazepine; Catatonia; Female; Humans; Lorazep | 2001 |
Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catatonia; Female; Hospitalization; Humans; Length of St | 1990 |
156 other studies available for lorazepam and Catatonia
Article | Year |
---|---|
Catatonia in a 16-Year Old.
Topics: Adolescent; Catatonia; Humans; Lorazepam; Marijuana Abuse; Problem Behavior; Psychiatric Department, | 2021 |
A Case Report of Scrupulosity Presenting as Catatonia in a Patient With Both OCD and OCPD.
Topics: Catatonia; Depressive Disorder, Major; Female; Humans; Lorazepam; Obsessive-Compulsive Disorder | 2022 |
Creutzfeldt-Jakob disease presenting as catatonia with desaturation on lorazepam challenge.
Topics: Catatonia; Creutzfeldt-Jakob Syndrome; Humans; Lorazepam | 2022 |
Low-Dose Lorazepam in the Treatment of Catatonia.
Topics: Catatonia; Humans; Lorazepam | 2022 |
Recurrent Catatonia: Infection and Immunity in an Idiopathic Illness.
Topics: Adolescent; Catatonia; Encephalitis; Female; Humans; Lorazepam; Mental Disorders; Olanzapine | 2023 |
Catatonic Coma in a Patient With Schizophrenia Receiving Palliative Care With Reversal of Symptoms With Lorazepam.
Topics: Catatonia; Coma; Humans; Lorazepam; Palliative Care; Schizophrenia | 2023 |
Clonazepam Treatment of Adolescent Catatonia in A Setting of Lorazepam-Related Hypotension.
Topics: Adolescent; Catatonia; Clonazepam; Humans; Lorazepam | 2023 |
[Ketamine and lorazepam combination as an alternative to electroconvulsive therapy for catatonia in late-life depression: A case report].
Topics: Catatonia; Depression; Electroconvulsive Therapy; Humans; Ketamine; Lorazepam | 2023 |
Memantine for pediatric catatonia - Experience of Al-Manara CAP centre from Kuwait.
Topics: Catatonia; Child; Humans; Kuwait; Lorazepam; Memantine | 2023 |
Baclofen and catatonia: a case report.
Topics: Adult; Baclofen; Catatonia; Female; Humans; Lorazepam; Psychotic Disorders; Young Adult | 2022 |
Cannabis-Induced Catatonia in a 15-Year-Old Male: A Case Report.
Topics: Adolescent; Cannabis; Catatonia; Humans; Lorazepam; Male; Prognosis | 2023 |
Resistant Catatonia in a 10-year-old Child: A Case Report.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Catatonia; Child; Electroconvulsive Therapy; Huma | 2023 |
Speech as an Unusual Presentation of Catatonia.
Topics: Catatonia; Female; GABA Modulators; Humans; Lorazepam; Middle Aged; Speech | 2019 |
Catatonia in patients with dementia: a case report.
Topics: Anti-Anxiety Agents; Catatonia; Dementia; Humans; Lorazepam; Male; Middle Aged; Prognosis; Treatment | 2019 |
[Malignant neuroleptic syndrome: An atypical case in an adolescent affected by bipolar I disorder associated with catatonic syndrome].
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Catatonia; Electroencephalography; Humans; Hypno | 2020 |
Contracture in chronic catatonia and its response to lorazepam.
Topics: Adult; Catatonia; Chronic Disease; Female; Humans; Lorazepam; Schizophrenic Psychology; Treatment Ou | 2020 |
Catatonia as a feature of down syndrome: An under-recognised entity?
Topics: Adolescent; Anticonvulsants; Catatonia; Child; Down Syndrome; Female; Humans; Lorazepam; Male; Retro | 2020 |
Misdiagnosis of Catatonia.
Topics: Benzodiazepines; Catatonia; Diagnostic Errors; Humans; Lorazepam | 2020 |
Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism.
Topics: Aged; Atrial Fibrillation; Basal Ganglia; Betacoronavirus; C-Reactive Protein; Catatonia; Coronaviru | 2020 |
Mixed etiology catatonia.
Topics: Catatonia; Cholecystitis, Acute; Humans; Hypokalemia; Hyponatremia; Lorazepam; Male; Middle Aged; Pr | 2020 |
Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting.
Topics: Catatonia; Emergency Service, Hospital; Humans; Lorazepam; Mental Disorders; Psychiatric Status Rati | 2021 |
Catatonia in a 12-Year-Old Child.
Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Catatonia; Central Nervous System St | 2021 |
Recurring catatonia due to varying causes: A case report.
Topics: Catatonia; Humans; Lorazepam; Recurrence | 2021 |
Case of paediatric catatonia precipitated by antipsychotic withdrawal in a child with autism spectrum disorder.
Topics: Adolescent; Antipsychotic Agents; Autism Spectrum Disorder; Catatonia; Female; Humans; Lorazepam; Ri | 2021 |
Lorazepam challenge test for catatonia.
Topics: Catatonia; Humans; Lorazepam | 2021 |
A Case of Nonmalignant Delirious Mania Successfully Treated With Lorazepam and Carbamazepine: A Proposed Diagnostic and Treatment Algorithm.
Topics: Algorithms; Carbamazepine; Catatonia; Humans; Lorazepam; Mania | 2021 |
Stupor in a catatonic patient due to an interaction between high-dose lorazepam and valproic acid: a case report.
Topics: Adult; Anti-Anxiety Agents; Antimanic Agents; Catatonia; Drug Interactions; Female; Humans; Lorazepa | 2021 |
Refractory catatonia in old age: a case report.
Topics: Aged; Benzodiazepines; Catatonia; Electroconvulsive Therapy; Humans; Lorazepam; Male; Schizophrenia | 2021 |
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy.
Topics: Adolescent; Anticonvulsants; Catatonia; Clonazepam; Humans; Lorazepam; Male; Risperidone; Treatment | 2021 |
The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients.
Topics: Adolescent; Adult; Aged; Catatonia; Combined Modality Therapy; Electroconvulsive Therapy; Female; GA | 2017 |
Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Topics: Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; | 2017 |
Resurgence of catatonia following tapering or stoppage of lorazepam - A case series and implications.
Topics: Adult; Catatonia; Female; GABA Modulators; Humans; Lorazepam; Male; Psychotic Disorders; Recurrence; | 2017 |
The catatonic pupil: An unprivileged entity.
Topics: Adult; Antipsychotic Agents; Catatonia; Female; Humans; Lorazepam; Male; Psychotic Disorders; Pupil | 2018 |
Intermittent catatonia and complex automatisms caused by frontal lobe epilepsy in dementia.
Topics: Aged, 80 and over; Anticonvulsants; Automatism; Catatonia; Dementia; Diagnosis, Differential; Electr | 2017 |
Response of Catatonia to Amisulpride and Lorazepam in an Adolescent with Schizophenia.
Topics: Adolescent; Amisulpride; Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Humans; Lorazepam; Ma | 2018 |
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy.
Topics: Benzodiazepines; Catatonia; Drug Tolerance; Humans; Intellectual Disability; Lorazepam; Male; Middle | 2018 |
A dramatic case of a woman discovered after 7 months of untreated catatonia.
Topics: Catatonia; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Hypnotics and Seda | 2018 |
Catatonia After Liver Transplantation.
Topics: Aged; Catatonia; Female; GABA Modulators; Humans; Liver Transplantation; Lorazepam; Male; Middle Age | 2018 |
Catatonia Associated With a
Topics: Anticonvulsants; Catatonia; Child, Preschool; Humans; Lorazepam; Mutation; NAV1.2 Voltage-Gated Sodi | 2018 |
Catatonia due to alprazolam withdrawal.
Topics: Alprazolam; Antipsychotic Agents; Catatonia; Comorbidity; Humans; Lorazepam; Male; Middle Aged; Pati | 2018 |
A Case of Catatonia Nearly Mistaken for Hepatic Encephalopathy.
Topics: Catatonia; Female; GABA Modulators; Hepatic Encephalopathy; Humans; Lorazepam; Middle Aged | 2019 |
Temporal glioblastoma presenting as catatonia.
Topics: Anti-Anxiety Agents; Catatonia; Chemotherapy, Adjuvant; Depression; Glioblastoma; Humans; Lorazepam; | 2019 |
Persistent catatonia for 1.5 years finally resolved with electroconvulsive therapy.
Topics: Adult; Aortic Valve Stenosis; Catatonia; Electroconvulsive Therapy; Heart Valve Prosthesis Implantat | 2013 |
Electroconvulsive treatment in catatonia of cerebrovasculo-coagulopathy: a case report.
Topics: Adult; Antipsychotic Agents; Catatonia; Cerebrovascular Disorders; Depression, Postpartum; Electroco | 2013 |
A 59-year-old woman who is awake yet unresponsive and stuporous after liver transplantation.
Topics: Anticonvulsants; Catatonia; End Stage Liver Disease; Female; Humans; Liver Transplantation; Lorazepa | 2013 |
Cavum septum pellucidum and cavum vergae with late-onset catatonia.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Brain; Catatonia; Cysteine; Electroconvulsive Therapy; Fem | 2013 |
Agitation after minor trauma: combativeness as a cardinal catatonic feature.
Topics: Catatonia; Diagnosis, Differential; Electroencephalography; Female; Humans; Hypnotics and Sedatives; | 2013 |
Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience.
Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; | 2013 |
Catatonia after deep brain stimulation successfully treated with lorazepam and right unilateral electroconvulsive therapy: a case report.
Topics: Aged; Anti-Anxiety Agents; Bipolar Disorder; Catatonia; Combined Modality Therapy; Deep Brain Stimul | 2014 |
Successful use of right unilateral ECT for catatonia: a case series.
Topics: Adolescent; Adult; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive | 2014 |
Immediate response to lorazepam in a patient with 17 years of chronic catatonia.
Topics: Anticonvulsants; Catatonia; Chronic Disease; Humans; Longitudinal Studies; Lorazepam; Male; Middle A | 2013 |
Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy.
Topics: Aged; Atrophy; Catatonia; Combined Modality Therapy; Dopamine Agents; Electroconvulsive Therapy; Fem | 2013 |
Lorazepam withdrawal catatonia: a case report.
Topics: Catatonia; Humans; Lorazepam; Male; Middle Aged; Substance Withdrawal Syndrome | 2013 |
Catatonia in the ICU: something worth knowing*.
Topics: Catatonia; Female; Humans; Intensive Care Units; Lorazepam; Male | 2014 |
An undiagnosed stupor in the acute medical unit: a case of malignant catatonia.
Topics: Catatonia; GABA Modulators; Glasgow Coma Scale; Humans; Lorazepam; Male; Middle Aged; Stupor | 2015 |
Synthetic marijuana use and development of catatonia in a 17-year-old male.
Topics: Adolescent; Cannabinoids; Cannabis; Catatonia; Designer Drugs; Electroconvulsive Therapy; Humans; Il | 2014 |
The authors reply.
Topics: Catatonia; Female; Humans; Intensive Care Units; Lorazepam; Male | 2015 |
Catatonia in the ICU.
Topics: Catatonia; Female; Humans; Intensive Care Units; Lorazepam; Male | 2015 |
Pulmonary embolism in a psychiatric patient.
Topics: Adult; Aggression; Antipsychotic Agents; Autopsy; Benzodiazepines; Bipolar Disorder; Catatonia; Deat | 2014 |
Catatonia and cannabis withdrawal: A case report.
Topics: Adult; Catatonia; Excitatory Amino Acid Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Mal | 2016 |
Pervasive refusal syndrome: A misnomer for catatonia.
Topics: Catatonia; Child; Child Development Disorders, Pervasive; Diagnosis, Differential; Early Medical Int | 2015 |
Malignant catatonia responsive to low doses of lorazepam: case report.
Topics: Adult; Anticonvulsants; Catatonia; Humans; Lorazepam; Male | 2016 |
A Woman With Catatonia, What To Do After ECT Fails: A Case Report.
Topics: Antimanic Agents; Catatonia; Electroconvulsive Therapy; Electroencephalography; Female; GABA Modulat | 2016 |
[Catatonia is often overlooked in child and adolescent psychiatry].
Topics: Adolescent; Adolescent Psychiatry; Anticonvulsants; Bipolar Disorder; Catatonia; Child Psychiatry; H | 2016 |
Relapses and recurrences of catatonia: 30-case analysis and literature review.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Clozapine; Depressive Disorder | 2016 |
Dexamethasone-induced catatonia in a patient with multiple myeloma.
Topics: Catatonia; Dexamethasone; GABA Modulators; Glucocorticoids; Humans; Lorazepam; Male; Middle Aged; Mu | 2016 |
Consultation Dilemma Catatonia in a Patient with Prior TBI: MentaI or Medical Disorder?
Topics: Adult; Anticonvulsants; Behavior Observation Techniques; Brain Injuries; Catatonia; Depression; Diag | 2015 |
Parenteral lorazepam's unavailability in Australia and the impact for catatonic patients.
Topics: Aged; Catatonia; Electroconvulsive Therapy; Humans; Infusions, Parenteral; Lorazepam; Male | 2017 |
Sudden-Onset Catatonia Following Clozapine Withdrawal: A Case Report.
Topics: Antipsychotic Agents; C-Reactive Protein; Catatonia; Clozapine; Creatine Kinase; Dantrolene; Drug Mo | 2016 |
Maintenance lorazepam for treatment of recurrent catatonic states: A case series and implications.
Topics: Adolescent; Adult; Catatonia; Female; Humans; Lorazepam; Male; Recurrence; Young Adult | 2016 |
Suspected Delirium Predicts the Thoroughness of Catatonia Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Catatonia; Delirium; Electroconvulsive | 2017 |
Acute Urinary Retention and Catatonia in a Schizophrenic Male Patient.
Topics: Antipsychotic Agents; Catatonia; Diagnosis, Differential; GABA Modulators; Humans; Lorazepam; Male; | 2016 |
The Lorazepam and Diazepam Protocol for Catatonia Due to General Medical Condition and Substance in Liaison Psychiatry.
Topics: Adult; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Diazepam; Female; Follow-Up | 2017 |
Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient.
Topics: Catatonia; Child; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Infusions, Intraven | 2017 |
[Immobility in patients with advanced dementia may actually be a form of a Lorazepam-reversible catatonia].
Topics: Catatonia; Dementia; GABA Modulators; Humans; Lorazepam | 2008 |
Reversal of preoperative catatonic state by surgical resection of an adult-onset craniopharyngioma: case report and review of the literature.
Topics: Brain; Catatonia; Craniopharyngioma; Hormones; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mid | 2009 |
Electroconvulsive therapy for malignant catatonia in adolescence.
Topics: Adolescent; Anti-Anxiety Agents; Catatonia; Diagnosis, Differential; Electroconvulsive Therapy; Huma | 2009 |
Lorazepam and diazepam for relieving catatonic features precipitated by initial hemodialysis in a uremic patient: a case report.
Topics: Adult; Catatonia; Diazepam; Humans; Hypnotics and Sedatives; Lorazepam; Male; Renal Dialysis; Uremia | 2010 |
Recurrent opisthotonus in catatonia: An atypical presentation.
Topics: Adult; Catatonia; Diagnosis, Differential; Dystonia; Electroconvulsive Therapy; GABA Modulators; Hum | 2009 |
Catatonia and CPK elevation in neurosyphilis: role of plural pharmacodynamic mechanisms.
Topics: Adult; Aripiprazole; Catatonia; Creatine Kinase; Dose-Response Relationship, Drug; Doxycycline; Huma | 2009 |
Catatonia after right temporal lobe resection.
Topics: Adult; Anticonvulsants; Catatonia; Epilepsy, Temporal Lobe; Humans; Levetiracetam; Lorazepam; Male; | 2010 |
[Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
Topics: Antimanic Agents; Antipsychotic Agents; Brain; Catatonia; Clozapine; Diagnosis, Differential; Dopami | 2010 |
Response rate of lorazepam in catatonia: a developing country's perspective.
Topics: Adolescent; Adult; Catatonia; Developing Countries; Female; Humans; India; Lorazepam; Male; Reaction | 2010 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinica | 2010 |
The curious case of a catatonic patient.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Delayed-Acti | 2011 |
Lorazepam, fluoxetine and packing therapy in an adolescent with pervasive developmental disorder and catatonia.
Topics: Adolescent; Catatonia; Child; Child Development Disorders, Pervasive; Fluoxetine; GABA Modulators; H | 2010 |
[Catatonia].
Topics: Adult; Catatonia; Female; Humans; Lorazepam; Male; Mental Disorders; Mood Disorders; Psychotic Disor | 2010 |
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Fema | 2010 |
Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn.
Topics: Aged; Aged, 80 and over; Anxiety Disorders; Catatonia; Depressive Disorder; Depressive Disorder, Maj | 2011 |
Catatonia in alcohol withdrawal: a case report.
Topics: Adult; Catatonia; Ethanol; GABA Modulators; Humans; Lorazepam; Male; Substance Withdrawal Syndrome | 2011 |
Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB.
Topics: Aged; Amitriptyline; Catatonia; Cerebrovascular Circulation; Female; Humans; Iofetamine; Lewy Body D | 2011 |
Anti-NMDA receptor encephalitis versus pediatric catatonia.
Topics: Adolescent; Adult; Autoimmune Diseases of the Nervous System; Benzodiazepines; Catatonia; Electrocon | 2011 |
Monocyte abnormality in catatonia: revisiting the immune theory of catatonia.
Topics: Antipsychotic Agents; Catatonia; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Lorazep | 2011 |
An unusual presentation of catatonia in a patient with schizoaffective disorder.
Topics: Behavior; Catatonia; Depressive Disorder; Female; Fibrin Fibrinogen Degradation Products; Humans; Hy | 2011 |
Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report.
Topics: Catatonia; Clonazepam; Drug Therapy, Combination; Female; Humans; Lorazepam; Risperidone; Young Adul | 2011 |
Catatonia and encephalopathy associated with paliperidone palmitate.
Topics: Aged; Antipsychotic Agents; Catatonia; Female; Humans; Isoxazoles; Lorazepam; Male; Neuroleptic Mali | 2012 |
Recurrent clozapine and lorazepam withdrawal psychosis with catatonia.
Topics: Adult; Antipsychotic Agents; Catatonia; Clozapine; Disease Management; Female; GABA Modulators; Huma | 2012 |
Lorazepam withdrawal-induced catatonia.
Topics: Catatonia; Female; Humans; Hypnotics and Sedatives; Lorazepam; Middle Aged; Substance Withdrawal Syn | 2012 |
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Do | 2011 |
Catatonia associated with hyponatremia treated with electroconvulsive therapy.
Topics: Adrenal Insufficiency; Anticonvulsants; Catatonia; Dehydration; Electroconvulsive Therapy; Female; H | 2012 |
Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration.
Topics: Adult; Benzodiazepines; Catatonia; Combined Modality Therapy; Depressive Disorder, Major; Electrocon | 2012 |
A 22-year-old graduate student with bizarre behavior.
Topics: Anti-Anxiety Agents; Catatonia; Diagnosis, Differential; Emergency Service, Hospital; Humans; Loraze | 2013 |
Temporal competency in catatonia.
Topics: Adult; Anti-Anxiety Agents; Catatonia; Electroconvulsive Therapy; Humans; Informed Consent; Lorazepa | 2002 |
Catatonic features noted in patients with post-partum mental illness.
Topics: Adult; Benzodiazepines; Catatonia; Cross-Sectional Studies; Depression, Postpartum; Depressive Disor | 2004 |
Catatonia in juvenile corrections.
Topics: Adolescent; Catatonia; Clozapine; Humans; Juvenile Delinquency; Lithium; Lorazepam; Male; Prisoners; | 2004 |
Chronic 'speech catatonia' with constant logorrhea, verbigeration and echolalia successfully treated with lorazepam: a case report.
Topics: Adult; Catatonia; Chronic Disease; Echolalia; Female; Humans; Hypnotics and Sedatives; Lorazepam; Re | 2004 |
Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Anxiety Agents; Anti-HIV Agents; Antipsychotic Agent | 2005 |
PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis.
Topics: Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Basal Ganglia Diseases; Catatoni | 2005 |
A16-year-old girl with excited catatonia treated with low-dose oral Lorazepam.
Topics: Adolescent; Bipolar Disorder; Catatonia; Delirium; Dose-Response Relationship, Drug; Female; Humans; | 2005 |
Topiramate effect in catatonia: a case series.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Cataplexy; Catatonia; Dose-Res | 2006 |
[Benzodiazepines in the treatment of catatonia].
Topics: Anti-Anxiety Agents; Benzodiazepines; Catatonia; Evidence-Based Medicine; Female; Humans; Lorazepam; | 2006 |
Catatonia: subtype or syndrome in DSM?
Topics: Amobarbital; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lorazepam; Me | 2006 |
Benzodiazepines in catatonia associated with systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Catatonia; Diazepam; Electroencephalography; Female; GABA Modulator | 2006 |
Lorazepam-reversible catatonia in the elderly can mimic dementia, coma and stroke.
Topics: Aged, 80 and over; Catatonia; Coma; Dementia; Diagnosis, Differential; GABA Modulators; Humans; Lora | 2007 |
Catatonia or no catatonia: still beyond lorazepam/amobarbital.
Topics: Amobarbital; Catatonia; Humans; Lorazepam; Treatment Outcome | 2007 |
GABA(A) versus GABA(B) in catatonia.
Topics: Anxiety Disorders; Catatonia; Chest Pain; Delirium; GABA Modulators; Humans; Lorazepam; Male; Middle | 2007 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relation | 2007 |
A vanishing lesion in the temporal lobe associated with schizophrenialike psychosis and catatonia.
Topics: Adult; Aggression; Antipsychotic Agents; Brain Diseases; Catatonia; Delusions; Diffusion Magnetic Re | 2007 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Choline | 2008 |
Intravenous lorazepam in neuroleptic-induced catatonia.
Topics: Adult; Aged; Antipsychotic Agents; Catatonia; Female; Haloperidol; Humans; Injections, Intravenous; | 1983 |
Benzodiazepines and the psychopathology of catatonia.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Catatonia; Diazepam; Humans; Lorazepam; Male | 1994 |
Benzodiazepines in the treatment of catatonic syndrome.
Topics: Adolescent; Adult; Benzodiazepines; Catatonia; Diazepam; Electroconvulsive Therapy; Female; Humans; | 1994 |
Treatment of catatonic stupor with oral lorazepam in 14-year-old psychotic boy.
Topics: Adolescent; Catatonia; Haloperidol; Humans; Lorazepam; Male; Psychotic Disorders | 1993 |
Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers.
Topics: Adult; Catatonia; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 1994 |
Catatonia: the tension insanity.
Topics: Carbamazepine; Catatonia; Diazepam; Female; Humans; Lorazepam; Male | 1993 |
Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.
Topics: Adult; Catatonia; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration S | 1996 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; D | 1996 |
ECT for lorazepam-refractory catatonia.
Topics: Adolescent; Catatonia; Drug Resistance; Electroconvulsive Therapy; Electroencephalography; Humans; H | 1996 |
Possibility of LSD-induced catatonia.
Topics: Anti-Anxiety Agents; Catatonia; Diazepam; Dose-Response Relationship, Drug; Drug Administration Sche | 1995 |
The syndrome of lethal catatonia.
Topics: Adult; Bromocriptine; Catatonia; Diagnosis, Differential; Dopamine Agonists; Female; Humans; Hypnoti | 1995 |
Advances in the diagnosis and treatment of catatonia.
Topics: Anti-Anxiety Agents; Catatonia; Combined Modality Therapy; Electroconvulsive Therapy; Humans; Loraze | 1996 |
Catatonia associated with hyponatremia.
Topics: Anti-Anxiety Agents; Catatonia; Humans; Hyponatremia; Lorazepam; Male; Middle Aged; Psychiatric Stat | 1997 |
Catatonia due to mixed sedative withdrawal.
Topics: Adult; Catatonia; Depressive Disorder; Female; Humans; Lorazepam; Meprobamate; Substance Withdrawal | 1997 |
Catatonia in an adolescent with Prader-Willi Syndrome.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Haloperidol; Humans; Lorazepam; Male; Neurologic Examin | 1997 |
Brief report: catatonia in autistic disorders.
Topics: Adolescent; Anti-Anxiety Agents; Autistic Disorder; Catatonia; Disease Progression; Humans; Lorazepa | 1998 |
Treatment-refractory catatonia, ECT, and parenteral lorazepam.
Topics: Catatonia; Electroconvulsive Therapy; Forensic Psychiatry; Humans; Informed Consent; Legal Guardians | 1999 |
Treatment-refractory catatonia, ECT, and parenteral lorazepam.
Topics: Administration, Oral; Adult; Aged; Catatonia; Depressive Disorder; Drug Administration Schedule; Ele | 1999 |
Catatonia responsive to lorazepam: a case report.
Topics: Aged; Bipolar Disorder; Catatonia; Diagnosis, Differential; Female; Hip Fractures; Humans; Lorazepam | 1999 |
Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia.
Topics: Adult; Anti-Anxiety Agents; Biomechanical Phenomena; Catatonia; Electroencephalography; Electromyogr | 2000 |
AIDS-related psychosis with catatonia responding to low-dose lorazepam.
Topics: Adult; AIDS Dementia Complex; Catatonia; Humans; Lorazepam; Male | 1992 |
NMS and lethal catatonia.
Topics: Catatonia; Clozapine; Diagnosis, Differential; Humans; Lorazepam; Neuroleptic Malignant Syndrome | 1992 |
The treatment of catatonia: benzodiazepines of ECT?
Topics: Benzodiazepines; Catatonia; Electroconvulsive Therapy; Humans; Lorazepam | 1992 |
Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity.
Topics: Adult; Arousal; Autonomic Nervous System; Catatonia; Combined Modality Therapy; Creatine Kinase; Del | 1991 |
Lorazepam and catatonia.
Topics: Brain; Catatonia; Electroencephalography; Epilepsy, Temporal Lobe; Humans; Lorazepam | 1991 |
Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial.
Topics: Adult; Catatonia; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged | 1990 |
Lorazepam monotherapy for catatonic stupor.
Topics: Adult; Catatonia; Female; Humans; Lorazepam | 1989 |
Benzodiazepines and catatonia: a case report.
Topics: Aged; Catatonia; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Lorazepam | 1989 |
Benzodiazepines for catatonic symptoms, stupor, and mutism.
Topics: Anti-Anxiety Agents; Benzodiazepines; Catatonia; Depressive Disorder; Diazepam; Female; Flumazenil; | 1988 |
Psychogenic catatonia treated with lorazepam.
Topics: Adult; Catatonia; Female; Humans; Lorazepam; Male; Psychophysiologic Disorders; Schizophrenia, Catat | 1988 |
Lorazepam: therapeutic for catatonic schizophrenia?
Topics: Catatonia; Humans; Lorazepam; Schizophrenia, Catatonic | 1988 |
Lorazepam for treatment of catatonic symptoms and severe psychomotor retardation.
Topics: Catatonia; Humans; Lorazepam; Psychomotor Disorders | 1988 |
Lorazepam for psychogenic catatonia.
Topics: Adult; Aged; Catatonia; Humans; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Psychophysi | 1987 |
Treatment of catatonia with low-dose lorazepam.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Catatonia; Depressive Disorder; Female; Humans; L | 1987 |
Intravenous lorazepam in psychogenic catatonia.
Topics: Adult; Catatonia; Female; Humans; Injections, Intravenous; Lorazepam | 1987 |
Use of lorazepam in treatment-resistant catatonia.
Topics: Adult; Catatonia; Female; Humans; Lorazepam | 1986 |
Lorazepam use and catatonic syndrome.
Topics: Catatonia; Electroconvulsive Therapy; Humans; Lorazepam; Male; Middle Aged; Time Factors | 1985 |